Search Results - "BATOROVA, A."

Continuous infusion of coagulation factor concentrates during intensive treatment by Holme, P. A., Tjønnfjord, G. E., Batorova, A.

“…In clinical management of bleeds and surgical procedures in patients suffering from bleeding disorders either repetitive bolus injections (BI) or continuous…”
Get full text

European principles of inhibitor management in patients with haemophilia by Giangrande, P L F, Hermans, C, O'Mahony, B, de Kleijn, P, Bedford, M, Batorova, A, Blatný, J, Jansone, K

“…In spite of recent major advances in the understanding and treatment of inhibitor development in patients with haemophilia, multidisciplinary management of…”
Get full text

European principles of inhibitor management in patients with haemophilia: implications of new treatment options by Hermans, C, Giangrande, P. L. F, O'Mahony, B, de Kleijn, P, Bedford, M, Batorova, A, Blatný, J, Jansone, K, Astermark, J, Crato, M, d'Oiron, R, Dougall, A, Fijnvandraat, K, Granhaug, S, Jiménez-Yuste, V, JokiÄ, M, Lobet, S, Nolan, B, Peyvandi, F, Ryan, A

“…Keywords: Haemophilia, Guidelines, Inhibitors, Factor VIII, Factor IX, Bypassing agents, Emicizumab, Immune tolerance…”
Get full text

The use of granulocyte colony stimulating factor after autologous hematopoietic stem cell transplantation by Farkas, F, Mistrik, M, Batorova, A

“…Restrospective study to evaluate the efficacy of early vs. delayed initiation of G-CSF after autologous hematopoietic stem cell transplantation (AHSCT) in…”
Get full text

Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants by Eikelboom, J W, Kozek-Langenecker, S, Exadaktylos, A, Batorova, A, Boda, Z, Christory, F, Gornik, I, Kėkštas, G, Kher, A, Komadina, R, Koval, O, Mitic, G, Novikova, T, Pazvanska, E, Ratobilska, S, Sütt, J, Winder, A, Zateyshchikov, D

“…Non-vitamin K antagonist oral anticoagulants (NOACs), which inhibit thrombin (dabigatran) and factor Xa (rivaroxaban, apixaban, edoxaban) have been introduced…”
Get more information

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report by ASTERMARK, J., ALTISENT, C., BATOROVA, A., DINIZ, M. J., GRINGERI, A., HOLME, P. A., KARAFOULIDOU, A., LOPEZ-FERNÁNDEZ, M. F., REIPERT, B. M., ROCINO, A., SCHIAVONI, M., Von DEPKA, M., WINDYGA, J., FIJNVANDRAAT, K.

“…The development of inhibitors to the infused factor in patients with haemophilia is a serious clinical problem. Recent evidence suggests that alongside the…”
Get full text

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations by HERMANS, C., ALTISENT, C., BATOROVA, A., CHAMBOST, H., DE MOERLOOSE, P., KARAFOULIDOU, A., KLAMROTH, R., RICHARDS, M., WHITE, B., DOLAN, G.

“…Although most surgical and invasive procedures can be performed safely in patients with haemophilia, the optimal level and duration of replacement therapy…”
Get full text

Current view and outcome of ITI therapy - A change over time? by Holstein, K, Batorova, A, Carvalho, M, Fijnvandraat, K, Holme, P, Kavakli, K, Lambert, T, Rocino, A, Jiménez-Yuste, V, Astermark, J

“…Abstract Introduction Inhibitor development in people with haemophilia is a serious complication that may require intensive and costly interventions. The goal…”
Get full text

Cardiovascular events and atherogenic lipid profile in chronic myeloid leukemia patients treated with nilotinib versus imatinib by Petrikova, L, Slezakova, K, Sninska, Z, Harvanova, L, Martisova, M, Hatalova, A, Mistrik, M, Batorova, A, Mladosievicova, B

“…The aim of this study was to assess cardiotoxicity and potential adverse effects related to lipid metabolism during treatment with tyrosine kinase inhibitors…”
Get full text

Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies by Napolitano, M., Di Minno, M. N. D., Batorova, A., Dolce, A., Giansily-Blaizot, M., Ingerslev, J., Schved, J.-F., Auerswald, G., Kenet, G., Karimi, M., Shamsi, T., Ruiz de Sáez, A., Dolatkhah, R., Chuansumrit, A., Bertrand, M. A., Mariani, G.

“…Introduction A paucity of data exists on the incidence, diagnosis and treatment of bleeding in women with inherited factor VII (FVII) deficiency. Aim Here we…”
Get full text

Neonatal bleeding in haemophilia: a European cohort study by Richards, M., Lavigne Lissalde, G., Combescure, C., Batorova, A., Dolan, G., Fischer, K., Klamroth, R., Lambert, T., Lopez-Fernandez, M., Pérez, R., Rocino, A., Fijnvandraat, K.

“…Summary Birth is the first haemostatic challenge for a child with haemophilia. Our aim was to examine the association between perinatal risk factors and major…”
Get full text

Recommendations for assessment, monitoring and follow-up of patients with haemophilia by DE MOERLOOSE, P., FISCHER, K., LAMBERT, T., WINDYGA, J., BATOROVA, A., LAVIGNE-LISSALDE, G., ROCINO, A., ASTERMARK, J., HERMANS, C.

“…Over the last few decades, clinical follow‐up of patients with haemophilia has become more complex as a result of the introduction of new treatment strategies,…”
Get full text

Longitudinal evaluation of markers of hemostasis in pregnancy by Hammerova, L, Chabada, J, Drobny, J, Batorova, A

“…The aim of this study was to establish the physiologic changes in hemostasis during pregnancy and to find the association between the factor V Leiden mutation…”
Get full text

Continuous infusion in haemophilia: current practice in Europe by BATOROVA, A., HOLME, P., GRINGERI, A., RICHARDS, M., HERMANS, C., ALTISENT, C., LOPEZ-FERNÁNDEZ, M., FIJNVANDRAAT, K.

“…Continuous infusion (CI) of factor VIII (FVIII) is an effective method for replacement therapy in haemophilia. Recently, concerns have been raised regarding…”
Get full text

Inhibitors to factor VII in congenital factor VII deficiency by Batorova, A., Mariani, G., Kavakli, K., de Saez, A. R., Caliskan, Ü., Karimi, M., Pinotti, M., Napolitano, M., Dolce, A., Sørensen, B., Ingerslev, J.

Get full text

Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene by HERRMANN, F. H., WULFF, K., AUERSWALD, G., SCHULMAN, S., ASTERMARK, J., BATOROVA, A., KREUZ, W., POLLMANN, H., RUIZ-SAEZ, A., DE BOSCH, N., SALAZAR-SANCHEZ, L.

“…The congenital FVII deficiency (FVIID) is a rare haemorrhagic disorder with an autosomal recessive pattern of inheritance. Data on phenotype and the genotype…”
Get full text

Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery by Napolitano, M., Dolce, A., Batorova, A., Giansily-Blaizot, M., Ingerslev, J., Mirbehbahani, N., Di Minno, M. N. D., Lopez Fernandez, M. F., Karimi, M., Charoenkwan, P., Kavakli, K., Mariani, G.

Get full text

Invasive procedures and minor surgery in factor VII deficiency by MARIANI, G., DOLCE, A., NAPOLITANO, M., INGERSLEV, J., GIANSILY-BLAIZOT, M., DI MINNO, M. D., AUERSWALD, G., DE SAEZ, A. R., TAGLIAFERRI, A., BATOROVA, A.

Get full text

Graft-versus-host disease management by Mistrik, M, Bojtarova, E, Sopko, L, Masakova, L, Roziakova, L, Martinka, J, Batorova, A

“…Graft-versus-host disease (GVHD) remains a major problem of allogeneic hematopoietic-stem cell transplantation (HSCT) and an obstacle for successful outcome…”
Get full text

Special lectures in haemophilia management by BATOROVA, A., HIGH, K. A., GRINGERI, A.

“…During the last two decades major advances have been achieved in the management of haemophilia. Modern approaches aimed at preventing the recurrent bleedings…”
Get full text